Protagonist Therapeutics, Inc. (NASDAQ:PTGX) | WebDisclosure

Basculer en Français

8725	Companies
153652	Keywords
89184	Articles
82604	Press releases

Headlines Articles Press releases Protagonist Therapeutics, Inc.

Home
Companies
Protagonist Therapeutics, Inc.

BRIEF

published on 05/21/2025 at 13:10, 30 days 2 hours ago

Protagonist Therapeutics participera à la conférence Jefferies Global Healthcare 2025

Produits Biopharmaceutiques Rusfertide Thérapeutique Protagoniste Icotorokina Conférence Sur Les Soins De Santé 2025
BRIEF

published on 05/21/2025 at 13:10, 30 days 2 hours ago

Protagonist Therapeutics to Attend Jefferies Global Healthcare Conference 2025

Biopharmaceuticals Protagonist Therapeutics Rusfertide Healthcare Conference 2025 Icotorokina
PRESS RELEASE

published on 05/21/2025 at 13:05, 30 days 2 hours ago

Protagonist Therapeutics to Participate in the Jefferies Global Healthcare Conference 2025
Protagonist Therapeutics to present at Jefferies Global Healthcare Conference on June 4, 2025. Learn about company overview and pipeline drug candidates

Biopharmaceutical Company Clinical Studies Protagonist Therapeutics Jefferies Global Healthcare Conference Pipeline Drug Candidates
BRIEF

published on 05/09/2025 at 14:10, 1 month 11 days ago

Les données de l'essai de phase 3 de Protagonist Therapeutics montrent des résultats positifs pour les traitements du psoriasis

Essais Cliniques Thérapeutique Protagoniste Icotrokinra PN-881 Traitements Du Psoriasis
BRIEF

published on 05/09/2025 at 14:10, 1 month 11 days ago

Protagonist Therapeutics' Phase 3 Trial Data Shows Positive Results for Psoriasis Treatments

Clinical Trials Protagonist Therapeutics Icotrokinra PN-881 Psoriasis Treatments
PRESS RELEASE

published on 05/09/2025 at 14:05, 1 month 11 days ago

Protagonist Announces Icotrokinra Phase 3 Data on Difficult-to-Treat Scalp and Genital Psoriasis and Preclinical Data on PN-881 Presented at the Society for Investigative Dermatology Annual Meeting
Protagonist Therapeutics presents new data on icotrokinra and PN-881 at SID Annual Meeting showcasing significant skin clearance and safety profile

Protagonist Therapeutics Psoriasis Icotrokinra PN-881 IL-17 Pathway
BRIEF

published on 05/06/2025 at 22:10, 1 month 13 days ago

Protagonist Therapeutics annonce ses résultats financiers du premier trimestre 2025

Résultats Financiers Essais Cliniques Rusfertide Réserves De Trésorerie Icotrokinra
BRIEF

published on 05/06/2025 at 22:10, 1 month 13 days ago

Protagonist Therapeutics Announces First Quarter 2025 Financial Results

Financial Results Clinical Trials Cash Reserves Rusfertide Icotrokinra
PRESS RELEASE

published on 05/06/2025 at 22:05, 1 month 13 days ago

Protagonist Reports First Quarter 2025 Financial Results and Provides Corporate Update
Protagonist Therapeutics reports positive Phase 3 results for rusfertide in PV and icotrokinra in PsO and UC. Strong financial results support pipeline advancement

Financial Update Protagonist Therapeutics Rusfertide Phase 3 Results Icotrokinra
BRIEF

published on 04/23/2025 at 16:40, 1 month 26 days ago

Protagonist Therapeutics to Present on Rusfertide at ASCO 2025

Phase 3 Study Protagonist Therapeutics Rusfertide Polycythemia Vera ASCO 2025

1 2 ... 7

Accesswire

Published on 06/20/2025 at 15:00, 35 minutes ago

QS Energy Receives Initial Order for Multi-Year AOT Technology Deployment
Published on 06/20/2025 at 14:30, 1 hour 5 minutes ago

Brenmiller Energy Appoints Boaz Toshav to Serve as an Independent Director on the Board
Published on 06/20/2025 at 14:30, 1 hour 5 minutes ago

Solitario Resources Completes US$4.5 Million Private Placement
Published on 06/20/2025 at 13:50, 1 hour 45 minutes ago

EON Resources Inc. Announces EON Energy, LLC Has Agreed to Acquire South Justis Field in the Permian Basin in Lea County, New Mexico with 207 Million Barrels of Original Oil in Place on 5,360 Acres
Published on 06/20/2025 at 13:00, 2 hours 35 minutes ago

Organto Foods Announces Final Settlement of Convertible Debenture Obligations

View all ACCESSWIRE

EQS Group

Published on 06/20/2025 at 15:12, 22 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Aviva plc
Published on 06/20/2025 at 15:11, 23 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Published on 06/20/2025 at 15:00, 34 minutes ago

Zentra Group plc: Churchgate Land Sale
Published on 06/20/2025 at 13:00, 2 hours 34 minutes ago

ADLER Real Estate announces the results of its cash tender offer and consent solicitation relating to its outstanding €300 million secured notes
Published on 06/20/2025 at 12:16, 3 hours 19 minutes ago

Amundi Physical Metals plc: UK Final Terms

Les Echos

Published on 06/20/2025 at 10:31, 5 hours 3 minutes ago

Deezer déploie le premier système d’étiquetage IA au monde pour le streaming musical
Published on 06/20/2025 at 10:31, 5 hours 3 minutes ago

Deezer launches world’s first AI tagging system for music streaming
Published on 06/19/2025 at 23:00, 16 hours 35 minutes ago

Biophytis annonce la suspension provisoire de la cotation de son action
Published on 06/19/2025 at 23:00, 16 hours 35 minutes ago

Biophytis announces the temporary suspension of the trading of its shares
Published on 06/18/2025 at 18:00, 1 day 21 hours ago

Saint-Gobain enhances its digital construction chemicals platform with the acquisition of Maturix

View all LES ECHOS COMFI WIRE